Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. IRIX
IRIX logo

IRIX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IRIX News

Iridex's MicroPulse Technology Effectively Lowers Intraocular Pressure in Glaucoma Patients

Dec 11 2025Newsfilter

Iridex Publishes Study on Thermal Dynamics of Laser Treatments for Glaucoma

Dec 08 2025Globenewswire

Iridex Publishes Study on Thermal Dynamics of Laser Treatments for Glaucoma

Dec 08 2025Newsfilter

Iridex Corporation to Present at Sidoti Year-End Virtual Investor Conference

Dec 05 2025Globenewswire

LightPath Technologies Shares Rise 7%; Check Out 20 Stocks Making Moves in Premarket Trading

Nov 12 2025Benzinga

Iridex Meets Nasdaq Listing Requirements Again

Sep 09 2025SeekingAlpha

Iridex Reports 7 Percent Q2 Revenue Gain

Aug 13 2025NASDAQ.COM

Vicarious Surgical Announces Election of New Directors

Jun 30 2025Newsfilter

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

Jun 24 2025Newsfilter

Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025

Apr 14 2025Newsfilter

Iridex Announces Strategic Investment in the Company

Mar 19 2025Newsfilter

Iridex Comments on Recent Stock Price Volatility

Mar 14 2025Newsfilter

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Mar 13 2025Newsfilter

Iridex: Q4 Sales To Match Performance Of Prior Year

Jan 14 2025NASDAQ.COM

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024

Jan 14 2025Newsfilter

Iridex: Q4 Sales To Match Performance Of Prior Year

Jan 14 2025Business Insider